Simson API was established in 2023 as a vertically integrated manufacturer of APIs and intermediates. The company operates under Simson Pharma, a privately owned leader in pharmaceutical reference standards founded in 2011. Driven by a strong commitment to innovation, Simson API leverages extensive research and development capabilities along with a highly skilled workforce to deliver a broad range of chemistry solutions. Our expertise spans custom synthesis, process research, and large-scale manufacturing, supporting pharmaceutical companies worldwide with reliable, high-quality services.
Small and complex molecule synthesis and analytical development with emphasis on speed, flexibility, and quality.
Early phase chemistry development studies, stability studies, and scale-up.
Contract development and cGMP manufacturing to ensure high standards.
Custom synthesis of peptides and amino acids tailored to your needs.